Jane Street’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7K Sell
18,800
-18,100
-49% -$44.2K ﹤0.01% 10973
2026
Q1
$87.5K Buy
36,900
+24,800
+205% +$85.9K ﹤0.01% 10711
2025
Q4
$62.7K Buy
+12,100
New +$58.6K ﹤0.01% 10415
2021
Q4
Sell
-15,300
Closed -$218K 10617
2021
Q3
$218K Sell
15,300
-1,700
-10% -$26.4K ﹤0.01% 8725
2021
Q2
$283K Buy
+17,000
New +$317K ﹤0.01% 8248

Other funds holding ORGO

Jane Street's ORGO Position: Q2 2026 in Review

Jane Street reduced its Organogenesis Holdings (ORGO) stake by 90% in Q2 2026, selling an estimated $286K and leaving 12,299 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #11103.

Jane Street first reported a position in ORGO in Q2 2020 and has held it in 16 quarters since. The position peaked at $4.57M in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Jane Street held 12,299 shares of Organogenesis Holdings worth $29.9K as of Q2 2026.
  • Jane Street sold 117,034 Organogenesis Holdings shares in Q2 2026, an estimated $286K.
  • Organogenesis Holdings made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11103 holding.
  • Jane Street first reported a position in Organogenesis Holdings in Q2 2020 and has held it in 16 quarters since.
  • Jane Street's Organogenesis Holdings position peaked at $4.57M in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.